Glycerine trioleate
Glycerine trioleate could as a marker in the radioisotope method.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Mol Cancer Ther.2024, 1535-7163.
AMB Express2020. 10(1):126.
Front Microbiol.2023, 14:921653.
Molecules2022, 27(11):3606.
J Mater Chem B.2019, 7(39):5896-5919
Biol Pharm Bull.2021, 44(12):1891-1893.
Molecules.2021, 26(12):3652.
Eur J Pharmacol.2023, 950:175772.
Progress In Microbes & Molecular Biology2025, 8,1:a0000470.
Indian J. of Experimental Bio.2020, 9(58).
Related and Featured Products
Terap Arkh: 15-19, 1965
Use of labelled lipids for diagnosing steator-rhea in patients with chronic liver diseases [Reference:
WebLink]
METHODS AND RESULTS:
A radioisotope method with Glycerine trioleate and oleinic acid was used to study absorption and excretion of fat in 37 individuals (27 with chronic liver disease and 10 controls with no diseases of the digestive tract).
Pancreatic function (blood amylase, serum proteolytic activity, serum trypsin inhibition, double sugar load, etc) radiometry, and scanning of the liver). Analysis of the clinical picture and of the laboratory data shows that the liver and intestinal lesions play a role in the disorders of absorption and excretion of fat in the liver disease. Involvement of the pancreas is the most important factor in steatorrhea in this group of patients.
CONCLUSIONS:
The extent of pancreatic lesion is directly related to the activity and severity of liver cirrhosis. Treatment depends on the degree of pancreatic involvement.
